Cargando…

Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis

The effectiveness of screening programs for cervical cancer has benefited from the inclusion of Human papillomavirus (HPV) DNA assays; which assay to choose, however, is not clear based on previous reviews. Our review addressed test accuracy of Hybrid Capture II (HCII) and polymerase chain reaction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luu, Hung N, Dahlstrom, Kristina R, Mullen, Patricia Dolan, VonVille, Helena M, Scheurer, Michael E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699849/ https://www.ncbi.nlm.nih.gov/pubmed/23930214 http://dx.doi.org/10.1002/cam4.83

Ejemplares similares

Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings
por: Luu, Hung N., et al.
Publicado: (2013)

Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men
por: Luu, Hung N, et al.
Publicado: (2014)

The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia
por: Zhang, Chaoting, et al.
Publicado: (2018)

DNA aneuploidy with image cytometry for detecting dysplasia and carcinoma in oral potentially malignant disorders: A prospective diagnostic study
por: Li, Chenxi, et al.
Publicado: (2020)

Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer
por: Nagai, Kentaro, et al.
Publicado: (2014)

Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme
por: Macios, Anna, et al.
Publicado: (2021)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

The polymorphisms (rs3213801 and rs5744533) of DNA polymerase kappa gene are not related with glioma risk and prognosis: A case‐control study
por: Wu, Ying, et al.
Publicado: (2019)

Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older—A national cohort study
por: Hammer, Anne, et al.
Publicado: (2019)

Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV‐positive women attending public health centers in Addis Ababa city, Ethiopia
por: Shiferaw, Saba, et al.
Publicado: (2018)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications
por: Hu, Zheng, et al.
Publicado: (2018)

Implementing the 3T‐approach for cervical cancer screening in Cameroon: Preliminary results on program performance
por: Levy, Juliette, et al.
Publicado: (2020)

Performance of cervical cancer screening and triage strategies among women living with HIV in China
por: Duan, Rufei, et al.
Publicado: (2021)

A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Benard, Vicki B., et al.
Publicado: (2021)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Evidence‐based policy choices for efficient and equitable cervical cancer screening programs in low‐resource settings
por: Campos, Nicole G., et al.
Publicado: (2017)

Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3(Tyr705) phosphorylation
por: Sun, Xiaodong, et al.
Publicado: (2020)

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage
por: Wang, Min, et al.
Publicado: (2021)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
por: Abulizi, Guzhalinuer, et al.
Publicado: (2021)

Letter to the Editor Re: A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Castle, Philip E.
Publicado: (2021)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

HPV‐vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
por: Altobelli, Emma, et al.
Publicado: (2019)

Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high‐risk human papillomavirus cervical carcinomas
por: Liu, Jing Jing, et al.
Publicado: (2020)

A population‐based study of age‐related associations between vaginal pH and the development of cervical intraepithelial neoplasia
por: Teng, Peng, et al.
Publicado: (2020)

PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study
por: Lai, Hung-Cheng, et al.
Publicado: (2014)

Genetic variants within microRNA‐binding site of RAD51B are associated with risk of cervical cancer in Chinese women
por: Hang, Dong, et al.
Publicado: (2016)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019)

Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020)

A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women
por: Wu, Qiongyan, et al.
Publicado: (2017)

Adherence to follow‐up after the exit cervical cancer screening test at age 60–64: A nationwide register‐based study
por: Jørgensen, Susanne F., et al.
Publicado: (2021)

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China
por: Wang, Yuli, et al.
Publicado: (2018)

A public health approach to cervical cancer screening in Africa through community‐based self‐administered HPV testing and mobile treatment provision
por: Nakalembe, Miriam, et al.
Publicado: (2020)

Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community‐based cross‐sectional study
por: Natae, Shewaye F., et al.
Publicado: (2021)

A screening assistance system for cervical cytology of squamous cell atypia based on a two‐step combined CNN algorithm with label smoothing
por: Nambu, Yuta, et al.
Publicado: (2021)

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
por: Depuydt, Christophe E, et al.
Publicado: (2015)

An examination of racial differences in 5‐year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010
por: Weragoda, Janaka, et al.
Publicado: (2016)

Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
por: Clarke, Megan A., et al.
Publicado: (2021)

The artificial intelligence‐assisted cytology diagnostic system in large‐scale cervical cancer screening: A population‐based cohort study of 0.7 million women
por: Bao, Heling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ejqanet07hcarth4pc4satn6ag